Comparison

AST 487 European Partner

Item no. TMO-T4053-50mg
Manufacturer TargetMol
CASRN 630124-46-8
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Akeno-Stuart N, et al. The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells. Cancer Res. 2007 Jul 15;67(14):6956-64.
Smiles C(C1=C(C(F)(F)F)C=C(NC(NC2=CC=C(OC=3C=C(NC)N=CN3)C=C2)=O)C=C1)N4CCN(CC)CC4
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias NVP-AST 487
Shipping Condition Cool pack
Available
Manufacturer - Targets
c-RET|||FLT|||VEGFR|||c-Kit|||Bcr-Abl
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
529.56
Description
AST 487 (NVP-AST 487) is a RET kinase inhibitor, inhibiting RET autophosphorylation and activation of downstream effectors. It also can inhibit Flt-3.
Pathways
Cytoskeletal Signaling|||Apoptosis|||Tyrosine Kinase/Adaptors|||Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close